Long-Term Safety of an Eye Drop for Mild to Moderate Cataract
Part of Brain & nervous system, Eyes & vision clinical trials.
This is a long-term follow-up study to check the safety and effectiveness of an eye drop (REVISYON SDS100) for people with mild to moderate cataract. It is only open to people who already completed the first study for this drop.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have taken part in the first (EB-CE-01) study for this eye drop and have completed all its visits, including the last one (visit 12).
- You must be able and willing to follow the study instructions.
- The study doctor must review your medical history and say it is safe for you to participate.
- You cannot be taking part in any other clinical trial right now.
- You cannot have any mental health condition that would make it hard to follow the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests how safe and tolerable an investigational treatment (EO2002) is in adults having cataract surgery. It also looks at whether the treatment can be given without causing harmful effects in people with reduced cornea cell counts.
This study tests two different eye drops to see which one works better for treating dry eye symptoms in people having cataract surgery. If you have dry eyes and are planning cataract surgery, this trial may help find which drop offers more comfort.
This study compares different anti-inflammatory and pain-relief eye drops after cataract surgery to see which one works better. It focuses on whether preservative-free drops cause fewer problems (like irritation) while still protecting the eye during healing.
This study tests a new eye drop medicine to see if it is safe and how the body handles it. It is for healthy adults only, not for treating a condition.
This phase 1 trial tests the safety of an investigational eye drop called IVMED-85 in healthy adults aged 18-49. Participants will receive the eye drops and be monitored for any side effects over 6 weeks.
This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.
Hear when a new Cataract trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.